STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/dca70e7bf6ac2ed1e7353abc03a7aae0e5244bd1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more"></iframe>